C
Curative Biosciences Inc
OTC:CBDX
Curative Biosciences Inc
OTC:CBDX
Price:
0.0001
USD
Market Closed
Market Cap:
$25.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Curative Biosciences Inc
Cash Taxes Paid
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Curative Biosciences Inc
Cash Taxes Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Curative Biosciences Inc
OTC:CBDX
|
Cash Taxes Paid
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash Taxes Paid
$6.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash Taxes Paid
$3.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash Taxes Paid
$4.7B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash Taxes Paid
$3.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash Taxes Paid
$10.8B
|
CAGR 3-Years
59%
|
CAGR 5-Years
62%
|
CAGR 10-Years
27%
|
|
No Stocks Found
Curative Biosciences Inc
Glance View
Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
CBDX
Intrinsic Value
Not Available
C
See Also
What is Curative Biosciences Inc's Cash Taxes Paid?
Cash Taxes Paid
0
USD
0
USD
Based on the financial report for Mar 31, 2018, Curative Biosciences Inc's Cash Taxes Paid amounts to 0 USD.
